Evaluation of the Validity of the Prothrombin Time Internation Normalised Ratio (PT/INR) Measured at the point-of Care on the Arterial Bloodline of Haemodialysis Extracorporeal Blood Flow

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02902848

Acronym

COAGHEMO

Enrollment

Registered

2016-09-16

Start date

2015-03-31

Completion date

Unknown

Last updated

2016-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemodialysis

Brief summary

The purpose of this study is to evaluate the INR value of hemodialyzed patient coagulation state (prothrombin time) measured inside the therapeutical zone and thanks to a portable monitor. The values obtained at the point of care will be compared to the standard biological assessment.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age \> 18 * Haemodialyzed patient whose INR needs to be monitored * Patient not objecting to participate in the study

Design outcomes

Primary

Measure	Time frame
correlation ratio between point-of-care PT/INR value and standard laboratory assessement	5 months

Countries

France

Contacts

Primary ContactYannick Le meur, MD-PhD

yannick.lemeur@chu-brest.fr

Outcome results